Literature DB >> 20142713

Correlation of vascular endothelial growth factor with chemokines in the vitreous in diabetic retinopathy.

Yoshihiro Wakabayashi1, Yoshihiko Usui, Yoko Okunuki, Takeshi Kezuka, Masaru Takeuchi, Hiroshi Goto, Takuya Iwasaki.   

Abstract

PURPOSE: The purpose of this study was to simultaneously measure the concentrations of multiple cytokines, including vascular endothelial growth factor, in the vitreous of patients with diabetic retinopathy and to examine their relation with clinical findings.
METHODS: Vitreous samples from 46 eyes with diabetic retinopathy and 19 eyes with nondiabetic macular disease (controls) were used. Nine cytokines were simultaneously measured using a FACSCalibur flow cytometer.
RESULTS: Vascular endothelial growth factor, interleukin-8, monocyte chemotactic protein-1, interferon-inducible protein-10, and monokine induced by interferon-gamma were detected in the vitreous samples, and the concentrations were significantly (P < 0.001) higher in patients with diabetic retinopathy compared with control subjects. Vascular endothelial growth factor, interleukin-8, monocyte chemotactic protein-1, and monokine induced by interferon-gamma concentrations were significantly (P < 0.05) higher in active retinopathy than in inactive retinopathy. Furthermore, a significant (P < 0.01) positive correlation was observed between vascular endothelial growth factor concentration and interleukin-8, monocyte chemotactic protein-1, interferon-inducible protein-10, or monokine induced by interferon-gamma concentration in the vitreous.
CONCLUSION: Vascular endothelial growth factor, interleukin-8, monocyte chemotactic protein-1, interferon-inducible protein-10, and monokine induced by interferon-gamma were expressed at high levels locally in ocular tissues in diabetic retinopathy, and these cytokines may form a network and interact to impact the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20142713     DOI: 10.1097/IAE.0b013e3181bd2f44

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  23 in total

1.  Vitamin D insufficiency in diabetic retinopathy.

Authors:  John F Payne; Robin Ray; David G Watson; Cecile Delille; Eva Rimler; Julia Cleveland; Michael J Lynn; Vin Tangpricha; Sunil K Srivastava
Journal:  Endocr Pract       Date:  2012 Mar-Apr       Impact factor: 3.443

Review 2.  Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment.

Authors:  Steven F Abcouwer; Thomas W Gardner
Journal:  Ann N Y Acad Sci       Date:  2014-03-27       Impact factor: 5.691

Review 3.  Current knowledge on diabetic retinopathy from human donor tissues.

Authors:  Jessica H Eisma; Jennifer E Dulle; Patrice E Fort
Journal:  World J Diabetes       Date:  2015-03-15

Review 4.  The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy.

Authors:  Alistair J Barber; Thomas W Gardner; Steven F Abcouwer
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-28       Impact factor: 4.799

5.  Angiogenic Factors and Cytokines in Diabetic Retinopathy.

Authors:  Steven F Abcouwer
Journal:  J Clin Cell Immunol       Date:  2013

6.  Advanced glycation end-product accumulation reduces vitreous permeability.

Authors:  On-Tat Lee; Samuel D Good; Ricardo Lamy; Max Kudisch; Jay M Stewart
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

7.  Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion.

Authors:  Yukihiko Suzuki; Mitsuru Nakazawa; Kaori Suzuki; Hitoshi Yamazaki; Yasuhiro Miyagawa
Journal:  Jpn J Ophthalmol       Date:  2011-05-03       Impact factor: 2.447

8.  Rehmannia glutinosa suppresses inflammatory responses elicited by advanced glycation end products.

Authors:  Gui-Hyun Baek; Yong-Suk Jang; Seung-Il Jeong; Jaeho Cha; Myungsoo Joo; Sang-Woo Shin; Ki-Tae Ha; Han-Sol Jeong
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

9.  Elevation of the vitreous body concentrations of oxidative stress-responsive apoptosis-inducing protein (ORAIP) in proliferative diabetic retinopathy.

Authors:  Yuta Suzuki; Takako Yao; Ko Okumura; Yoshinori Seko; Shigehiko Kitano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-05-06       Impact factor: 3.117

10.  Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes.

Authors:  Monique S Roy; Malvin N Janal; Juan Crosby; Robert Donnelly
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-13       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.